ZEISS showcases comprehensive workflow for full spectrum of retina care at EURETINA
ZEISS Medical Technology combines its diagnostic, surgical and digital technologies to support healthcare professionals in advancing retinal care.
At EURETINA in Paris, France, from Sept. 4 – 7, 2025, ZEISS Medical Technology combines its diagnostic, surgical and digital technologies to support healthcare professionals in advancing retinal care:
IMPROVE PATHOLOGY DETECTION: Now CE mark approved, CIRRUS® PathFinderTM AI decision support tool streamlines OCT data review; ICGA for CLARUS® 700 offers FA + ICG simultaneous capture.
ACCELERATE RETINA RESEARCH: AI-ready ZEISS Research Data Platform (RDP) empowers retina specialists to transform their clinical hypotheses into measurable outcomes through smarter, more efficient research.
TRANSFORM VITREORETINAL TREAMENT: TDC VELOCETM, the new high-speed cutter for the DORC EVA NEXUSTM platform, unlocks new possibilities for the platform’s proprietary VacuFlow VTi fluidics, further enabling the capabilities of the
SMART IOPTM system of the EVA NEXUS to provide constant intraoperative stability during surgery on one of the market’s most advanced dual-function, vitreoretinal and cataract surgical systems.
SETTING THE PACE IN VISUALIZATION: ZEISS ARTEVO 850 and ZEISS ARTEVO 750, now with updated ZEISS CALLISTO eye software, support confident decision making and elevate the surgical workflow in vitreoretinal and combined phacovitrectomy procedures.
More information can be found here.
BREAKING